{"items":["6028dcdb4bbba4003445e656","60116ecfadc5940017190b54","5fcd808e02ba2d00178a6be9"],"styles":{"galleryType":"Columns","groupSize":1,"showArrows":true,"cubeImages":true,"cubeType":"max","cubeRatio":1.3333333333333333,"isVertical":true,"gallerySize":30,"collageAmount":0,"collageDensity":0,"groupTypes":"1","oneRow":false,"imageMargin":21,"galleryMargin":0,"scatter":0,"rotatingScatter":"","chooseBestGroup":true,"smartCrop":false,"hasThumbnails":false,"enableScroll":true,"isGrid":true,"isSlider":false,"isColumns":false,"isSlideshow":false,"cropOnlyFill":false,"fixedColumns":1,"enableInfiniteScroll":true,"isRTL":false,"minItemSize":50,"rotatingGroupTypes":"","rotatingCropRatios":"","columnWidths":"","gallerySliderImageRatio":1.7777777777777777,"numberOfImagesPerRow":1,"numberOfImagesPerCol":1,"groupsPerStrip":0,"borderRadius":0,"boxShadow":0,"gridStyle":1,"mobilePanorama":false,"placeGroupsLtr":true,"viewMode":"preview","thumbnailSpacings":4,"galleryThumbnailsAlignment":"bottom","isMasonry":false,"isAutoSlideshow":false,"slideshowLoop":false,"autoSlideshowInterval":4,"bottomInfoHeight":0,"titlePlacement":"SHOW_ON_THE_RIGHT","galleryTextAlign":"center","scrollSnap":false,"itemClick":"nothing","fullscreen":true,"videoPlay":"hover","scrollAnimation":"NO_EFFECT","slideAnimation":"SCROLL","scrollDirection":0,"scrollDuration":400,"overlayAnimation":"FADE_IN","arrowsPosition":0,"arrowsSize":23,"watermarkOpacity":40,"watermarkSize":40,"useWatermark":true,"watermarkDock":{"top":"auto","left":"auto","right":0,"bottom":0,"transform":"translate3d(0,0,0)"},"loadMoreAmount":"all","defaultShowInfoExpand":1,"allowLinkExpand":true,"expandInfoPosition":0,"allowFullscreenExpand":true,"fullscreenLoop":false,"galleryAlignExpand":"left","addToCartBorderWidth":1,"addToCartButtonText":"","slideshowInfoSize":200,"playButtonForAutoSlideShow":false,"allowSlideshowCounter":false,"hoveringBehaviour":"NEVER_SHOW","thumbnailSize":120,"magicLayoutSeed":1,"imageHoverAnimation":"NO_EFFECT","imagePlacementAnimation":"NO_EFFECT","calculateTextBoxWidthMode":"PERCENT","textBoxHeight":0,"textBoxWidth":200,"textBoxWidthPercent":50,"textImageSpace":10,"textBoxBorderRadius":0,"textBoxBorderWidth":0,"loadMoreButtonText":"","loadMoreButtonBorderWidth":1,"loadMoreButtonBorderRadius":0,"imageInfoType":"ATTACHED_BACKGROUND","itemBorderWidth":1,"itemBorderRadius":0,"itemEnableShadow":false,"itemShadowBlur":20,"itemShadowDirection":135,"itemShadowSize":10,"imageLoadingMode":"BLUR","expandAnimation":"NO_EFFECT","imageQuality":90,"usmToggle":false,"usm_a":0,"usm_r":0,"usm_t":0,"videoSound":true,"videoSpeed":"1","videoLoop":false,"jsonStyleParams":"","gallerySizeType":"px","gallerySizePx":546,"allowTitle":true,"allowContextMenu":true,"textsHorizontalPadding":-30,"itemBorderColor":{"value":"rgba(237,77,11,0.39)"},"showVideoPlayButton":true,"galleryLayout":2,"targetItemSize":546,"selectedLayout":"2|bottom|1|max|true|0|true","layoutsVersion":2,"selectedLayoutV2":2,"isSlideshowFont":false,"externalInfoHeight":0,"externalInfoWidth":0.5},"container":{"width":546,"galleryWidth":567,"galleryHeight":0,"scrollBase":0,"height":null}}
FOCUSED ON PEOPLE & THERAPIES
Thank you to all the investors!
which participated in our campaign on the Pipelbiz crowdfunding site (ended 24/09/2020).
We reached our goal of raising 4M NIS.
Developing Novel, First in Class Drugs, Treating and Preventing
Type 2 Diabetes, Based on a Core-Technology-Platform.
Short Summary
Pipeline IND in process
Type 2 Diabetes Drug
Professor Chevion and co-inventors developed a family of non-steroidal chemical complexes, made of components approved for clinical use.
These New Chemical Entities constitute a protected PLATFORM of DRUGS, with proven efficacy and complete safety, for treatments of multiple indications. Concenter BioPharma is developing and commercializing the drug which treats and prevents Type 2 Diabetes.
The drug has 3 synergistic Mechanisms of Action, extensively tested in animal models of human diseases
(and anecdotal human cases).
Prof. DeFronzo presentation audio at the 17th World Congress
on Insulin Resistance. Diabetes & Cardiovascular Disease [2019]
Insulin Resistance All You Wanted to KnowProf. DeFronzo
ABOUT US & VISION
VISION
Becoming a global specialty biopharmaceutical company by advancing a pipeline of products that demonstrate vast potential for treating TYPE 2 DIABETES.
ABOUT
Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications.
Our PLATFORM is the result of extensive investigation of animal models of human diseases.
MEMBERS OF OUR PLATFORM ACT AS:
Potent anti-inflammatory agents, Strong iron-chelating agents, and Anti-biotic agents.
STRATEGY OVERVIEW
To rapidly advance from laboratory experiments to clinical trials in Type 2 Diabetes based on "shortcut"
regulatory routes, that enable a shorter time from the lab to treating patients.
Our initial focus is on a leveraging FDA 505(b)(2) designations and Expedited Pathway programs.
Our focus leverages the global demand-creating patient population of about 450 million people with Diabetes.
Our drug for treating Type 2 Diabetes (Pill) – extensively demonstrated as effective in both prevention and treatment of T2 Diabetes – by Restoring Insulin Resistance to Normal Levels!
Markedly inhibiting the appearance and the degree of hyperglycemia; lowering LDL; lowering body weight; reduction of cataract formation and diabetes-induced retinopathy.